Skip to content

National Health Investors NHI Common Stock Shares Outstanding

Common Stock Shares Outstanding at other companies

Alignment Healthcare logo
Alignment HealthcareALHC
$6.48M-54.4%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$121.56M
Dorman Products logo
Dorman ProductsDORM
$3.1M-56.9%
NuScale Power logo
NuScale PowerSMR
$48.3M-45.9%
Qualys, Inc. logo
Qualys, Inc.QLYS
$1.25M-94.7%
Doximity logo
DoximityDOCS
$435.27M-38.1%

Other financials

Income statement

See full
Revenue$115.1M+28.9%
Net income$40.1M+17.4%
EPS (diluted)$0.82+10.8%

Balance sheet

See full
Cash & equivalents$24.9M-81.8%
Total debt$1.4B+8.4%
Total equity$1.5B+6.2%
Total assets$2.9B+3.8%

Cash flow

See full
Operating cash flow$53.4M+15.0%

Valuation

See full
Market cap$3.54B+16.1%

Profitability

See full
Operating margin50.1%
Net margin36.9%-4.3pp
FCF margin70.1%

Returns & leverage

See full
Return on equity10.1%-0.5pp
Debt / equity0.9×0.0×

Where this comes from

Reported directly by National Health Investors in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: National Health Investors’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about National Health Investors's common stock shares outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is National Health Investors's common stock shares outstanding?
National Health Investors (NHI) reported common stock shares outstanding of $4.3M in Q1 2026.
How has National Health Investors's common stock shares outstanding changed year-over-year?
National Health Investors's common stock shares outstanding decreased by 60.6% year-over-year, from $10.9M to $4.3M.
What does common stock shares outstanding mean?
This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.